A detailed history of Dimensional Fund Advisors LP transactions in Exact Sciences Corp stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 803,376 shares of EXAS stock, worth $39.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
803,376
Previous 1,002,784 19.89%
Holding current value
$39.8 Million
Previous $42.4 Million 29.11%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$42.43 - $70.83 $8.46 Million - $14.1 Million
-199,408 Reduced 19.89%
803,376 $54.7 Million
Q2 2024

Aug 09, 2024

BUY
$41.33 - $74.26 $4.48 Million - $8.04 Million
108,296 Added 12.11%
1,002,784 $42.4 Million
Q1 2024

May 10, 2024

BUY
$56.27 - $73.77 $11.2 Million - $14.7 Million
198,946 Added 28.6%
894,488 $61.8 Million
Q4 2023

Feb 07, 2024

BUY
$59.06 - $75.72 $1.43 Million - $1.84 Million
24,259 Added 3.61%
695,542 $51.5 Million
Q3 2023

Nov 09, 2023

SELL
$65.94 - $99.04 $1.62 Million - $2.43 Million
-24,510 Reduced 3.52%
671,283 $45.8 Million
Q2 2023

Aug 09, 2023

BUY
$62.68 - $95.05 $2.25 Million - $3.41 Million
35,872 Added 5.44%
695,793 $65.3 Million
Q1 2023

May 12, 2023

BUY
$47.19 - $70.77 $5.16 Million - $7.75 Million
109,445 Added 19.88%
659,921 $44.7 Million
Q4 2022

Feb 09, 2023

BUY
$30.35 - $53.15 $1.5 Million - $2.62 Million
49,296 Added 9.84%
550,476 $27.3 Million
Q3 2022

Nov 10, 2022

BUY
$31.97 - $49.37 $125,482 - $193,777
3,925 Added 0.79%
501,180 $16.3 Million
Q2 2022

Aug 12, 2022

BUY
$35.61 - $76.23 $1.73 Million - $3.71 Million
48,615 Added 10.84%
497,255 $19.6 Million
Q1 2022

May 13, 2022

BUY
$57.56 - $82.54 $3.08 Million - $4.41 Million
53,454 Added 13.53%
448,640 $31.4 Million
Q4 2021

Feb 09, 2022

BUY
$72.5 - $100.68 $1.89 Million - $2.62 Million
26,058 Added 7.06%
395,186 $30.8 Million
Q3 2021

Nov 12, 2021

BUY
$90.24 - $124.05 $1.53 Million - $2.1 Million
16,908 Added 4.8%
369,128 $35.2 Million
Q2 2021

Aug 12, 2021

BUY
$93.66 - $139.27 $911,030 - $1.35 Million
9,727 Added 2.84%
352,220 $43.8 Million
Q1 2021

May 14, 2021

BUY
$116.57 - $155.01 $376,870 - $501,147
3,233 Added 0.95%
342,493 $45.2 Million
Q4 2020

Feb 25, 2021

BUY
$99.61 - $142.12 $33.8 Million - $48.2 Million
339,260 New
339,260 $45 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $8.77B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.